FindTrial
Sign In

A clinical study to evaluate the influence of strength of satva in Pulmonary Tuberculosis patients

Development of scale for the assessment of strength of Satva and to evaluate its influence on R�?jayakṣm�? with special reference to Pulmonary Tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041912
Enrollment
75
Registered
2022-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

None listed

Sponsors

Institute of Medical Science Banaras Hindu University Varanasi Uttar Pradesh India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Confirmed pulmonary tuberculosis patients irrespective of gender 2.Patients with well controlled comorbid conditions 3.Age group between 18-70 years

Exclusion criteria

Exclusion criteria: 1.Not willing to complete the consent process as describe in proforma. 2.Inability to comply with study procedures and methods. 3.HIV patients

Design outcomes

Primary

MeasureTime frame
To evaluate the type of Satva and its role in response to the treatment of Pulmonary Tuberculosis.Timepoint: 1.5yr—

Secondary

MeasureTime frame
To evaluate the association of types of Satva with adverse reactions and complications of Pulmonary Tuberculosis.Timepoint: 1.5 yr—

Countries

India

Contacts

Public ContactArunima P S

Banaras Hindu University

psbyadgi@bhu.ac.in9450711759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026